Effect on glucose control and quality of life for people with type 2 diabetes of using a device to measure glucose levels at home and send them to the clinic, rather than attending an out-patient clinic for blood tests
Not Applicable
Completed
- Conditions
- Type 2 Diabetes Mellitus (T2DM)Nutritional, Metabolic, Endocrine
- Registration Number
- ISRCTN15790927
- Lead Sponsor
- GPI SpA
- Brief Summary
2021 Results article in https://dx.doi.org/10.4103/VIT-1 (added 21/09/2021)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 161
Inclusion Criteria
1. Patients with type 2 diabetes mellitus (T2DM)
2. Diagnosis of DM made at least 1 year before the start of the study
3. Hypoglycemic treatment remained the same in the 3 months preceding the start of the study
Exclusion Criteria
1. Diabetes other than T2DM
2. Pregnant women
3. Chronic conditions other than T2DM
4. Unable to give informed consent
5. Dementia or psychiatric conditions that can affect a person's will or ability to participate in the study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method evel of glycated hemoglobin (GlyH) at the end of the study (18 months) in patients followed with telemedicine and in the control group when compared to baseline, with normal GlyH defined as <5.6%.
- Secondary Outcome Measures
Name Time Method